Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Breast Neoplasms × Methotrexate × Clear all

Phase

Phase 3 24 Phase 2 22 Phase NA 3 Phase 1/2 2 Phase 1 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 6 Lymphoma 3 Leukemia, T-Cell 2 Leukemia, Myeloid, Acute 2 Gestational Trophoblastic Disease 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Biphenotypic, Acute 1 Drug-Related Side Effects and Adverse Reactions 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Capecitabine 13 Paclitaxel 9 Cyclophosphamide 9 Docetaxel 8 Epirubicin 7 Gemcitabine 5 Doxorubicin 5 Trastuzumab 4 Letrozole 4 Carboplatin 4 pertuzumab 3 exemestane 3 Vinorelbine 3 AC protocol 3 Thiotepa 2 Taxes 2 Neoadjuvant Therapy 2 Melatonin 2 Lapatinib 2 Fluorouracil 2 Drug Therapy 2 Cisplatin 2 Albumin-Bound Paclitaxel 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 taxane 1 soluble LAG-3 protein, human 1 pyrotinib 1 pitavastatin 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204437 2016-02-10

ICE-II

GBG Forschungs GmbH

Phase 2/3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡